Research
Title : | A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy & safety of Vpm 1002 & immuvac vaccones in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients |
Area of research : | Medical Sciences |
Focus area : | Task Force (TF) |
Principal Investigator : | Ms. N. Wadhwa, Associate Professor, Translational Health Science & Technology Institute, Haryana |
Timeline Start Year : | 2019 |
Timeline End Year : | 2023 |
Details
Total Budget (INR): | 89,15,650 |
Organizations involved
Implementing Agency : | Translational Health Science & Technology Institute, Haryana |
Funding Agency : | Indian Council of Medical Research (ICMR) |